710 results on '"Rudelius, Martina"'
Search Results
102. Comparison of cyclic RGD peptides for αvβ3 integrin detection in a rat model of myocardial infarction
103. Schwere Candida-glabrata-Pankolitis und letale Aspergillus-fumigatus-Lungeninfektion vor dem Hintergrund einer Knochenmarkaplasie nach CD19-spezifischer CAR T-Zell-Therapie – ein Fallbericht
104. Publisher Correction : Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes (Nature Medicine, (2021), 27, 10, (1806-1817), )
105. The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma
106. Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection
107. Littoral Cell Angioma and Angiosarcoma of the Spleen: Report of Two Cases in Siblings and Review of the Literature
108. Human Induced Pluripotent Stem Cell-Derived Bone Marrow Organoids to Model Hematopoietic Development
109. Predicting the Clinical Course of Treatment with Midostaurin in Patients with Advanced Systemic Mastocytosis
110. Lysosomal Membrane Permeabilization Sensitizes Ctss-Hyperactive Tumors to BCL2-Targeting Therapies
111. Tracking of [ 18F]FDG-labeled natural killer cells to HER2/neu-positive tumors
112. Platelets contribute to postnatal occlusion of the ductus arteriosus
113. Sarcoid-Like Reaction in Non-Hodgkin’s Lymphoma—A Diagnostic Challenge for Deauville Scoring on 18F-FDG PET/CT Imaging
114. Implementation of Precision Oncology for Patients with Metastatic Breast Cancer in an Interdisciplinary MTB Setting
115. A missense mutation in the WD40 domain of murine Lyst is linked to severe progressive Purkinje cell degeneration
116. Clinical spectrum of primary adrenal lymphoma: results of a multicenter cohort study
117. In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging
118. Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection
119. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro
120. Cell tracking with gadophrin-2: a bifunctional contrast agent for MR imaging, optical imaging, and fluorescence microscopy
121. Highly efficient paramagnetic labelling of embryonic and neuronal stem cells
122. High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells
123. NPM-ALK–dependent expression of the transcription factor CCAAT/enhancer binding protein β in ALK-positive anaplastic large cell lymphoma
124. Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma
125. Histopathological analysis of cellular localization of cathepsins in abdominal aortic aneurysm wall
126. Expression of a Disintegrin and Metalloprotease in Human Abdominal Aortic Aneurysms
127. Lymphomas including Hodgkin lymphoma
128. Contributors
129. Depicting Adoptive Immunotherapy for Prostate Cancer in an Animal Model with Magnetic Resonance Imaging
130. NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU
131. Clinical spectrum of primary adrenal lymphoma: results of a multicenter cohort study
132. Transformation of diffuse large B cell lymphoma into dendritic sarcoma under CAR T cell therapy detected on 18F-FDG PET/CT
133. Prognostic value of indoleamine 2,3 dioxygenase in patients with higher‐risk myelodysplastic syndromes treated with azacytidine
134. EZH2 Loss Drives Resistance to Carboplatin and Paclitaxel in Serous Ovarian Cancers Expressing ATM
135. Indocyanine green–enhanced imaging of antigen-induced arthritis with an integrated optical imaging/radiography system
136. Multiple Biological Predictors for Vulnerable Carotid Lesions
137. Comparison of iron oxide labeling properties of hematopoietic progenitor cells from umbilical cord blood and from peripheral blood for subsequent in vivo tracking in a xenotransplant mouse model XXX 1
138. PARP14 is a novel target in STAT6mutant follicular lymphoma
139. Influence of platelet count at diagnosis and during the course of disease on prognosis in MDS patients.
140. A novel conditional NPM-ALK-driven model of CD30+ T-cell lymphoma mediated by a translational stop cassette
141. The IMiD-Target Cereblon Determines Transmembrane Protein Quality Control Promoting Tumor Metabolism
142. The Fanconi Anemia-Associated Protein NIPA Is Essential for the Nuclear Abundance of FANCD2
143. Long-term in vivo microscopy of CAR T cell dynamics during eradication of CNS lymphoma in mice
144. Serum Vitamin D Levels in Patients with Myelodysplastic Syndromes: A Retrospective Single-Center Analysis
145. MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma
146. Symmetric multifocal bone marrow involvement diagnosed by whole-body magnetic resonance imaging in a patient with B lymphoblastic lymphoma
147. NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU.
148. Imaging of chemokine receptor 4 expression in neuroendocrine tumors: a triple tracer comparative approach
149. The Aurora-Kinase A Phe31-Ile polymorphism as possible predictor of response to treatment in head and neck squamous cell carcinoma
150. RIG-I/MAVS and STING signaling promote gut integrity during irradiation- and immune-mediated tissue injury
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.